Meet Mark, Program Manager, In Vitro Diagnostic Regulations

Mark Rundell is a program manager of in vitro diagnostic regulations. Here is a peek at what he does and why he likes working for us. Watch the video.
Meet Mark, Program Manager, In Vitro Diagnostic Regulations

Meet your next favorite teammate! Mark Rundell is a program manager of in vitro diagnostic regulations at our Chaska, Minnesota location. Here is a peek at what he does and why he likes working for us.

Editorial Team
Editorial Team
The Beckman Coulter editorial team brings you timely news and resources focused on elevating clinical laboratory performance and advancing patient care.

Related Articles

Advancing Clinical Capabilities to Empower Better Outcomes

Advancing Clinical Capabilities to Empower Better Outcomes

Discover how our philosophy of Advancing Clinical Capabilities is helping us deliver greater insights in areas like women’s health, cardiovascular disease, infectious disease, and beyond.
Rethinking Heart Failure Diagnosis in an Era of Rising Obesity

Rethinking Heart Failure Diagnosis in an Era of Rising Obesity

As obesity rates climb toward 50% of the U.S. population, clinicians face a growing diagnostic challenge: obesity is associated with lower NT-proBNP levels, potentially masking heart failure in the patients most at risk.
The Global Burden of Cardiovascular Disease in Women

The Global Burden of Cardiovascular Disease in Women

Based on "Women's Hearts: Biomarkers for Precision-based Care," a webinar with Dr. Emily Lau, MD, MPH. Dr. Lau is a cardiologist and public health expert specializing in cardiovascular disease prevention, heart failure, and women’s cardiac health. Her research focuses on risk prediction, sex-based differences in cardiovascular disease, and strategies to improve outcomes through evidence-based care.